08-31-2023
SEK/share | |
Price | 211.60 |
Dividend | 0.00 |
Earnings | 14.01 |
Cash-flow | 13.74 |
Book value | 78.37 |
Equity | 73.35 |
Swedish Orphan Biovitrum is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Swedish Orphan Biovitrum is a company from Sweden, and his stocks are publicly traded.
Swedish Orphan Biovitrum stock dividend
Swedish Orphan Biovitrum paid a total dividend of 0 million SEK last year, for a market value of 71,732 millions (Market Cap 38,053 millions). Swedish Orphan Biovitrum dividend per share is 0.00 SEK, and his stock market price 211.60 SEK.
According to the chart below where dividend yield is displayed, Swedish Orphan Biovitrum, has a dividend yield of 0%, amount in contrast with the positive dividend offered by both the market average and companies from Sweden, Health Care industry, and Pharmaceuticals and Biotechnology sector. This lack of dividends of Swedish Orphan Biovitrum might harm the evolution of share price if the company is not clearly expanding his business.
In addition, you should compare Swedish Orphan Biovitrum stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the high Sweden dividend stocks list.
Swedish Orphan Biovitrum Dividend Payout
About the ability of Swedish Orphan Biovitrum to maintain his current dividend of SEK 0.00 per share, an amount that accounts for 0.00%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Swedish Orphan Biovitrum payout on ernings is currently 0.00%, which is lower than the market average and companies in his industry and sector.
The following figure shows payout ratios over earnings and cashflow of Swedish Orphan Biovitrum, compared againt world market average, Sweden companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.
Swedish Orphan Biovitrum Dividend History
Below you will find a table with the historical evolution of Swedish Orphan Biovitrum's dividend stock, both in percentage and in SEK, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).
Year | Yield | SEK | Paypout | Shares* |
Present | 0.00% | 0.00 | 0.00% | 339 |
2022 | 0.00% | 0.00 | 0.00% | 295 |
2021 | 0.00% | 0.00 | 0.00% | 295 |
2020 | 0.00% | 0.00 | 0.00% | 299 |
2019 | 0.00% | 0.00 | 0.00% | 294 |
2018 | 0.00% | 0.00 | 0.00% | 269 |
*In millions
Swedish Orphan Biovitrum Stock performance
Finally, last moth Swedish Orphan Biovitrum showed a return of 7.50% compared to a worldwide -2.49% average, and a -2.07% of Health Care firms. Over the last year, the company obtained a -6.00% versus a worldwide performance of a 8.71%. More detailed information can be seen in the following graph for Sweden and Pharmaceuticals and Biotechnology firms.